Roche SVP Details Digital Transformation Strategy
Daniele Iacovelli, SVP at Roche, outlined the company's approach to digital transformation, emphasizing business value over technology. Speaking on the Augmented Ops podcast, Iacovelli stated, "Digital isn’t about installing toys, it’s about fundamentally transforming business operations." Roche groups digital projects into strategic "value pools" and empowers its 12,000 technical operations staff with no-code and low-code platforms to democratize analytics and automation.
- To rationalize hundreds of digital projects, Roche consolidated them into 20 high-impact "value pools" to be scaled across sites, governed by a global operating model with product owners and a tech council. One such project is a Generative AI-powered assistant designed to streamline root cause analysis for quality deviations. - Roche is deploying AI-powered predictive applications to optimize biologics manufacturing by forecasting yields and identifying key drivers of process variability. This has led to a 5% to 10% increase in yields and a reduction of up to 50% in write-offs for products that don't meet critical quality attributes (CQAs). - The company is creating digital twins for over 100 consumable production lines at its Rotkreuz, Switzerland diagnostics facility. This initiative is part of a broader strategy that began with replacing paper-based records with electronic systems that interface with other operating systems for real-time data analysis. - A key part of the transformation involves moving from monolithic IT systems to a more flexible, composable architecture to increase speed and efficiency. This includes harmonizing ERP systems and building data products prioritized by the needs of the 20 value pools, rather than attempting to make all data accessible at once. - Roche's Basel drug substance manufacturing site was recognized as a "Global Advanced Digital Lighthouse" by the World Economic Forum for its use of AI and digital technologies to optimize productivity and sustainability. - The company is making significant capital investments in advanced manufacturing, including a €600 million diagnostics production center in Penzberg, Germany, and a $700 million Genentech facility in North Carolina focused on metabolic medicines. Both sites are designed with high levels of automation and digital capabilities. - To support the digital shift, Roche has established employee-led groups like the "Digital Ambassador Network" in Branchburg, New Jersey, and the "Data2Value Community" in Mannheim, Germany, to elevate digital skills and promote data-driven decision-making.
